BackSun Pharma Advanced Research Company Limited Overview

Sun Pharma Advanced Research Company Limited Total Current Liabilities

Latest total current liabilities for SPARC.BO: $1.8B.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$1.82B
↓ 63.05% YoYΔ $-3.10B vs prior year quarter

Peer trimmed avg / median

Loading

Sun Pharma Advanced Research Company Limited Total Current Liabilities History

Loading

Sun Pharma Advanced Research Company Limited vs. peers: Total Current Liabilities Comparison

Loading

Sun Pharma Advanced Research Company Limited Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Sun Pharma Advanced Research Company Limited (SPARC.BO) FAQ

Sun Pharma Advanced Research Company Limited posts a total current liabilities of $1.8B as of September 2026. That compares with $4.9B in the prior-year period — down 63.1% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Sun Pharma Advanced Research Company Limited's total current liabilities was $4.9B. The latest reading is $1.8B — a 63.1% year-over-year decrease (period ending September 2026). Use the history and growth charts on this page for a longer lookback.

Total Current Liabilities is one piece of Sun Pharma Advanced Research Company Limited's financial statement story. At $1.8B, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for SPARC.BO's total current liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Sun Pharma Advanced Research Company Limited's other metric pages and overview cover the third.